IR@PKUHSC  > 北京大学临床肿瘤学院  > 胸部肿瘤内科
学科主题临床医学
Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC
Wang, Zhijie; Chen, Rui; Wang, Shuhang; Zhong, Jia; Wu, Meina; Zhao, Jun; Duan, Jianchun; Zhuo, Minglei; An, Tongtong; Wang, Yuyan; Bai, Hua1; Wang, Jie
刊名PLOS ONE
2014-11-18
DOI10.1371/journal.pone.0110780
9期:11
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Multidisciplinary Sciences
研究领域[WOS]Science & Technology - Other Topics
关键词[WOS]TYROSINE KINASE INHIBITOR ; FACTOR RECEPTOR MUTATIONS ; LUNG-CANCER PATIENTS ; ACQUIRED-RESISTANCE ; NONINVASIVE DETECTION ; 1ST-LINE TREATMENT ; OPEN-LABEL ; GEFITINIB ; ERLOTINIB ; CHEMOTHERAPY
英文摘要

Background: Among advanced non-small cell lung cancer (NSCLC) patients with an acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKI), about 50% carry the T790M mutation, but this frequency in EGFR-TKI-naive patients and dynamic change during therapy remains unclear. This study investigated the quantification and dynamic change of T790M mutation in plasma cell-free DNA (cf-DNA) of advanced NSCLC patients to assess the clinical outcomes of EGFR-TKI therapy.

Materials and Methods: We retrospectively investigated 135 patients with advanced NSCLC who obtained progression-free survival (PFS) after EGFR-TKI for.6 months for their EGFR sensitive mutations and T790M mutation in matched pre-and post-TKI plasma samples, using denaturing high-performance liquid chromatography (DHPLC), amplification refractory mutation system (ARMS), and digital-PCR (D-PCR). Real-time PCR was performed to measure c-MET amplification.

Results: Detection limit of D-PCR in assessing the T790M mutation was approximately 0.03%. D-PCR identified higher frequency of T790M than ARMS in pre-TKI (31.3% vs. 5.5%) and post-TKI (43.0% vs. 25.2%) plasma samples. Patients with pre-TKI T790M showed inferior PFS (8.9 vs. 12.1 months, p = 0.007) and overall survival (OS, 19.3 vs. 31.9 months, p = 0.001) compared with those without T790M. In patients harboring EGFR sensitive mutation, high quantities of pre-TKI T790M predicted poorer PFS (p = 0.001) on EGFR-TKI than low ones. Moreover, patients who experienced increased quantity of T790M during EGFR-TKI treatment showed superior PFS and OS compared with those with decreased changes (p = 0.044 and p = 0.015, respectively).

Conclusion: Qualitative and quantitative T790M in plasma cf-DNA by D-PCR provided a non-invasive and sensitive assay to predict EGFR-TKI prognosis.

语种英语
WOS记录号WOS:000347121300007
项目编号81025012 ; 81330062 ; IRT13003 ; 320.6750.1361 ; 320.6750.12192
资助机构National Natural Science Foundation Distinguished Young Scholars ; National Natural Science Foundation Key Program ; Education Ministry Innovative Research Team Program ; Peking University-Tsinghua University Joint Center ; Wujieping Medicine Foundation
引用统计
被引频次:5[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62687
专题北京大学临床肿瘤学院_胸部肿瘤内科
作者单位1.Beijing Inst Canc Res, Beijing, Peoples R China
2.Beijing Canc Hosp, Minist Educ, Key Lab Carcinogenesis & Translat Res, Dept Thorac Med Oncol, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Wang, Zhijie,Chen, Rui,Wang, Shuhang,et al. Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC[J]. PLOS ONE,2014,9(11).
APA Wang, Zhijie.,Chen, Rui.,Wang, Shuhang.,Zhong, Jia.,Wu, Meina.,...&Wang, Jie.(2014).Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC.PLOS ONE,9(11).
MLA Wang, Zhijie,et al."Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC".PLOS ONE 9.11(2014).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Zhijie]的文章
[Chen, Rui]的文章
[Wang, Shuhang]的文章
百度学术
百度学术中相似的文章
[Wang, Zhijie]的文章
[Chen, Rui]的文章
[Wang, Shuhang]的文章
必应学术
必应学术中相似的文章
[Wang, Zhijie]的文章
[Chen, Rui]的文章
[Wang, Shuhang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。